Elizabeth L Yanik1, Meredith S Shiels2, Jodi M Smith3, Christina A Clarke4, Charles F Lynch5, Amy R Kahn6, Lori Koch7, Karen S Pawlish8, Eric A Engels2. 1. Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri. 2. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. 3. Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington. 4. GRAIL, Inc, Menlo Park, California. 5. Department of Epidemiology, University of Iowa, Iowa City, Iowa. 6. New York State Cancer Registry, New York, New York. 7. Illinois State Cancer Registry, Springfield, Illinois. 8. Cancer Epidemiology Services, New Jersey Department of Health, Trenton, New Jersey.
Abstract
BACKGROUND: Pediatric solid organ transplant recipients have a 100 to 200 times higher risk of non-Hodgkin lymphoma (NHL) than the general pediatric population. Consequently, transplant-related NHL may contribute considerably to the pediatric NHL burden in the United States. METHODS: A cohort study using a linkage between the US transplant registry and 16 cancer registries was conducted. Cancer incidence rates were calculated for people less than 20 years old in the transplant and general populations. Rates were applied to transplant registry and US census data to estimate pediatric NHL counts for transplant recipients and the general population. RESULTS: During 1990-2012, an estimated 22,270 NHLs were diagnosed in US children and adolescents; they included 628 cases diagnosed in transplant recipients. Thus, 2.82% of pediatric NHL diagnoses in the general population (95% confidence interval [CI], 2.45%-3.19%) occurred in transplant recipients. Among transplant recipients, the most common subtypes were diffuse large B-cell lymphoma (DLBCL; 64.5% of cases) and Burkitt lymphoma (BL; 8.6%). For DLBCL and BL, transplant recipients contributed 7.62% (95% CI, 6.35%-8.88%) and 0.87% (95% CI, 0.51%-1.23%) of diagnoses, respectively. The proportion of NHLs that occurred in transplant recipients was highest among children less than 5 years old (4.46%; 95% CI, 3.24%-5.69%) and in more recent calendar years (3.73% in 2010-2012; 95% CI, 2.07%-5.39%). DLBCL patterns were similar, with transplant recipients contributing 19.78% of cases among children less than 5 years old (95% CI, 12.89%-26.66%) and 11.4% of cases in 2010-2012 (95% CI, 5.54%-17.28%). CONCLUSIONS: Among children and adolescents, solid organ transplant recipients contribute a substantial fraction of NHL diagnoses, particularly DLBCL diagnoses. This fraction has increased over time. Prevention efforts targeted toward this group could reduce the overall pediatric NHL burden. Cancer 2017;123:4663-4671.
BACKGROUND: Pediatric solid organ transplant recipients have a 100 to 200 times higher risk of non-Hodgkin lymphoma (NHL) than the general pediatric population. Consequently, transplant-related NHL may contribute considerably to the pediatric NHL burden in the United States. METHODS: A cohort study using a linkage between the US transplant registry and 16 cancer registries was conducted. Cancer incidence rates were calculated for people less than 20 years old in the transplant and general populations. Rates were applied to transplant registry and US census data to estimate pediatric NHL counts for transplant recipients and the general population. RESULTS: During 1990-2012, an estimated 22,270 NHLs were diagnosed in US children and adolescents; they included 628 cases diagnosed in transplant recipients. Thus, 2.82% of pediatric NHL diagnoses in the general population (95% confidence interval [CI], 2.45%-3.19%) occurred in transplant recipients. Among transplant recipients, the most common subtypes were diffuse large B-cell lymphoma (DLBCL; 64.5% of cases) and Burkitt lymphoma (BL; 8.6%). For DLBCL and BL, transplant recipients contributed 7.62% (95% CI, 6.35%-8.88%) and 0.87% (95% CI, 0.51%-1.23%) of diagnoses, respectively. The proportion of NHLs that occurred in transplant recipients was highest among children less than 5 years old (4.46%; 95% CI, 3.24%-5.69%) and in more recent calendar years (3.73% in 2010-2012; 95% CI, 2.07%-5.39%). DLBCL patterns were similar, with transplant recipients contributing 19.78% of cases among children less than 5 years old (95% CI, 12.89%-26.66%) and 11.4% of cases in 2010-2012 (95% CI, 5.54%-17.28%). CONCLUSIONS: Among children and adolescents, solid organ transplant recipients contribute a substantial fraction of NHL diagnoses, particularly DLBCL diagnoses. This fraction has increased over time. Prevention efforts targeted toward this group could reduce the overall pediatric NHL burden. Cancer 2017;123:4663-4671.
Authors: Elizabeth L Yanik; Jodi M Smith; Meredith S Shiels; Christina A Clarke; Charles F Lynch; Amy R Kahn; Lori Koch; Karen S Pawlish; Eric A Engels Journal: Pediatrics Date: 2017-05 Impact factor: 7.124
Authors: Eric A Engels; Ruth M Pfeiffer; Joseph F Fraumeni; Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Robert A Wolfe; Nathan P Goodrich; A Rana Bayakly; Christina A Clarke; Glenn Copeland; Jack L Finch; Mary Lou Fleissner; Marc T Goodman; Amy Kahn; Lori Koch; Charles F Lynch; Margaret M Madeleine; Karen Pawlish; Chandrika Rao; Melanie A Williams; David Castenson; Michael Curry; Ruth Parsons; Gregory Fant; Monica Lin Journal: JAMA Date: 2011-11-02 Impact factor: 157.335
Authors: E L Yanik; L M Nogueira; L Koch; G Copeland; C F Lynch; K S Pawlish; J L Finch; A R Kahn; B Y Hernandez; D L Segev; R M Pfeiffer; J J Snyder; B L Kasiske; E A Engels Journal: Am J Transplant Date: 2016-05-12 Impact factor: 9.369
Authors: C A Clarke; L M Morton; C Lynch; R M Pfeiffer; E C Hall; T M Gibson; D D Weisenburger; O Martínez-Maza; S K Hussain; J Yang; E T Chang; E A Engels Journal: Br J Cancer Date: 2013-06-11 Impact factor: 9.075
Authors: Anne-Michelle Noone; Ruth M Pfeiffer; Joanne F Dorgan; Laurence S Magder; Jonathan S Bromberg; Charles F Lynch; Cyllene R Morris; Karen S Pawlish; Eric A Engels Journal: Cancer Date: 2019-04-29 Impact factor: 6.921
Authors: Ana-Iris Schiefer; Elisabeth Salzer; Anna Füreder; Zsolt Szepfalusi; Thomas Müller-Sacherer; Wolf-Dietrich Huber; Ina Michel-Behnke; Anita Lawitschka; Herbert Pichler; Georg Mann; Caroline Hutter; Ingrid Simonitsch-Klupp; Andishe Attarbaschi Journal: Cancer Med Date: 2019-07-03 Impact factor: 4.452
Authors: Kira Endén; Juuso Tainio; Atte Nikkilä; Ilkka Helanterä; Arno Nordin; Mikko P Pakarinen; Hannu Jalanko; Kirsi Jahnukainen; Timo Jahnukainen Journal: Pediatr Nephrol Date: 2020-05-11 Impact factor: 3.714